We isolated spontaneous mutants from Escherichia coli K-12 with low-level resistance to norfloxacin. These mutants were classified into the following three types on the basis of their properties: (i) NorA appeared to result for mutation in the gyrA locus for the A subunit of DNA gyrase; (ii) NorB showed low-level resistance to quinolones and other antimicrobial agents (e.g., cefoxitin, chloramphenicol, and tetracycline), and the norB gene was considered to map at about 34 min on the E. coli K-12 chromosome; (iii) NorC was less susceptible to norfloxacin and ciprofloxacin but was hypersusceptible to hydrophobic quinolones such as nalidixic acid and rosoxacin, hydrophobic antibiotics, dyes, and detergents. Susceptibility to bacteriophages and the hydrophobicity of the NorC cell surface also differed from that of the parent strain. The norC gene was located near the lac locus at 8 min on the E. coli K-12 chromosome. Both NorB and NorC mutants had a lower rate of norfloxacin uptake, and it was found that the NorB mutant was altered in OmpF porin and that the NorC mutant was altered in both OmpF porin and apparently in the lipopolysaccharide structure of the outer membrane.
ity against gram-positive and gram-negative bacteria, including Pseudomonas aeruginosa, have been developed recently (12, 18, 33, 34) . They also show high antibacterial activity against nalidixic acid-resistant strains including mutational resistant strains such as gyrA and nalB mutants of Escherichia coli K-12 (14, 28) . There is incomplete crossresistance between the new quinolones and nalidixic acid (14, 17, 28, 35) .
The high antibacterial activity of new quinolones (e.g., norfloxacin and ciprofloxacin) might be due to their strong inhibitory action on DNA gyrase, which is the target enzyme of quinolones (K. Sato, Y. Inoue, T. Fujii, H. Aoyama, M. Inoue, and S. Mitsuhashi, personal communication). Recently, we found that the bacterial outer membrane penetration mechanisms of new quinolones differed from those of old quinolones such as nalidixic and piromidic acids (13) .
To study the mechanisms of resistance to norfloxacin, the first-developed new quinolone, spontaneous norfloxacinresistant mutants were isolated from E. coli K-12 and their properties were investigated. Three classes of mutants showed less susceptibility to norfloxacin; one class appeared to consist of gyrA mutants, while the other two were novel mutants that showed alteration in norfloxacin uptake. In this report we describe the biochemical and genetic properties of these new mutants in detail.
(This work was presented in part at the 14th International Congress of Chemotherapy, Kyoto, Japan, 23-28 June 1985.)
MATERIALS AND METHODS
Bacterial strains and phages. Bacterial strains and phages used in this study are listed in Table 1 . Spontaneous norfloxacin-resistant mutants (KEA12, KEA13, KEA16) were iso-* Corresponding author.
lated from E. coli KL-16 by plating on nutrient agar plates containing norfloxacin. Strain KJC-1, a gIpT derivative of JC1552, was made by fosfomycin selection as described previously (21) . The phages Tula and TuIb were kindly provided by S. Mizushima of Nagoya University, Nagoya, Japan.
Drugs. AM-833, ciprofloxacin, norfloxacin, ofloxacin, oxolinic acid, pipemidic acid, piromidic acid, and rosoxacin were synthesized by Central Research Laboratories of Kyorin Pharmaceutical Co., Ltd. Ampicillin, cefoxitin, chloramphenicol, cloxacillin, fosfomycin, gentamicin, nalidixic acid, novobiocin, streptomycin, and tetracycline were obtained from commercial sources.
Determination of hydrophobicity of quinolones. Hydrophobicity of quinolones was determined by a previously described method (13) . Solutions (10 ,ug/ml) of quinolones were made in 0.1 M phosphate buffer (pH 7.2). After shaking with an equal volume of n-octanol at 25°C for 48 h and centrifuging at 1,870 x g for phase separation, the concentrations of quinolones in the aqueous phase were determined by a spectrophotometric assay. The partition coefficients (P) were expressed as the ratio of the amount of compound in the n-octanol phase to that in the aqueous phase.
Media. Antibiotic medium 3, Mueller-Hinton medium,
Mueller-Hinton agar, and nutrient agar were purchased from Difco Laboratories, Detroit, Mich. L-broth and L-agar were prepared as described previously (22) . Minimal medium (citrate-free minimal A medium) (6) (24) . The bacteria were grown at 37°C with shaking in antibiotic medium 3. The bacteria were harvested at early log phase, washed twice, and suspended in PUM buffer (pH 7.1), which consisted of the following: 22.2 g of K2HPO4 * 3H20, 7.26 g of KH2PO4, 1.8 g of urea, 0.2 g of MgSO4 * 7H20 and distilled water to 1,000 ml. p-Xylene (2 ml) was added to 5 ml of bacterial cell suspension (A570 = 1.0) in PUM buffer. Following 10 min of preincubation at 37°C, the mixtures were agitated uniformly with a Vortex mixer for 120 s. After a 15-min period during which the p-xylene phase rose completely, the aqueous phase was removed, and the light absorbance was determined at 570 nm. Cell-surface hydrophobicity was expressed as the ratio of decrease in absorbance of the aqueous phase.
Characterization of outer membrane proteins. Outer membrane proteins were prepared by the method of Sawai et al. (27) and analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis as described by Uemura and Mizushima (32) . Gels were stained with Coomassie brilliant blue. To identify OmpF and OmpC porin proteins, we used as a reference the outer membrane proteins prepared from strain KE7 (OmpC deficient) and strain KEll (OmpF deficient), which have been described previously (13) .
Uptake of norfloxacin by the bacterial cells. The uptake of norfloxacin by bacterial cells was measured by a method previously described (13) . Cells were grown to mid-log phase at 37°C in antibiotic medium 3, and the bacterial cell suspension (A570 = 0.7) was prepared with the same medium. Norfloxacin was added to the bacterial suspensions to a final concentration of 10 ,ug/ml, and the cultures were incubated at 37°C with shaking. After the indicated times, 10 ml of the culture was chilled, and the cells were sedimented by centrifugation and washed once in 2 ml of saline. The cells were then suspended in 1 ml of saline. The suspension was immersed in boiling water for 7 min and then centrifuged. The concentration of norfloxacin in the supernatants was measured by a bioassay with E. coli NIHJ JC-2.
RESULTS
Isolation of norfloxacin-resistant mutants. Spontaneous norfloxacin-resistant mutants were isolated from E. Susceptibility to quinolones and other chemical agents. The MIC was determined for quinolones (Table 2 ) and other agents, including various antibiotics (Table 3) . Strain KEA12 showed especially high resistance to nalidixic and piromidic acids. The MICs of norfloxacin and other new quinolones such as ciprofloxacin, ofloxacin, and AM-833 for KEA12 were increased eightfold over those of KL-16. Mutant KEA12 showed no changes in susceptibility to other antimicrobial agents, dyes, or detergents. Strain KEA13 showed low-level resistance to all the quinolones that were tested. This mutant also showed a slight but reproducible increase in resistance to ampicillin, chloramphenicol, cloxacillin, novobiocin, and tetracycline and a larger increase in resistance to cefoxitin, but it showed no increase in resistance to aminoglycoside antibiotics. The third mutant (KEA16) was unique in that it showed a slight but reproducible increase (generally two-to fourfold) in resistance to hydrophilic (9) . It was also demonstrated that norA was cotransducible with gipT at frequencies of about 50% by P1 transduction (data not shown). These results suggest that KEA12 is due to a mutation in the gyrA locus for subunit A of DNA gyrase. In Fig. 1 type of mutant (KEA13) with JC1552. Transfer of the norB gene appeared at about 10 min after his and at about 7 min before trp; the resistance gene therefore was considered to be at about 34 min on the map of E. coli K-12. Uninterrupted mating with LC607, AB3505, and JC1552 suggested that the norC gene (in KEA16) was located near lac ( Table 4 ). All of the norfloxacin-resistant transconjugants tested had the same pattern of susceptibility to quinolones and other chemical agents as the donor strain (KEA16). However, it was not possible to analyze the position of norC by P1 transduction because this mutant was resistant to P1 phage (see below).
Phage susceptibility and hydrophobicity of the cell surface of mutants. The susceptibility of mutants to chemical agents suggested that KEA13 and KEA16 might be altered in outer membrane properties. Because alterations of the outer membrane have been related to changes in bacteriophage susceptibility, we investigated the susceptibility of these mutants to various phages, including phages Tula and TuIb (Table 5 ).
The norA mutant was susceptible to all bacteriophages tested, as was the parent strain. On the other hand, KEA13 was resistant to Tula phage and KEA16 was resistant to phages Tula, P1, and T4. It is well known that Tula and TuIb use the OmpF and OmpC porin proteins, respectively, as parts of their receptors (19) and that P1 and T4 phages use the lipopolysaccharide of the outer membrane as a receptor (4, 29) . The phage susceptibility test indicated that KEA13 might be altered in OmpF porin proteins and that KEA16 might be altered in both OmpF porin proteins and the lipopolysaccharide of the outer membrane. The cell surface of KEA16 also became more hydrophobic than that of the parent strain (Table 5) .
Analysis of outer membrane proteins of mutants. Outer membrane proteins of mutants were prepared and separated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis. In Fig. 2 it is demonstrated that OmpF proteins were significantly reduced in KEA13 and KEA16 mutants in comparison with the parent strain. It appeared that OmpC proteins were also slightly reduced in the KEA16 mutant. The phage susceptibility of these mutants was confirmed by this electrophoretic analysis of outer membrane proteins.
Uptake of norfloxacin by bacterial cells. It has been reported that the mechanism of resistance to nalidixic acid in E. coli is an alteration in subunits of DNA gyrase and permeability through the bacterial cell membrane (3, 8, 16, 17, 28, 35) . To confirm whether an alteration of permeability of norfloxacin into bacterial cells could be the mechanism of resistance in norB and norC mutants, we measured their uptake of norfloxacin and compared it with that of the parent strain (Fig. 3) . Mutants KEA13 and KEA16 showed about a twofold lower norfloxacin uptake than the wild-type strain (KL-16), suggesting that alterations in the OmpF protein of the outer membrane lead to decreased permeability of norfloxacin through the outer membrane of E. coli K-12.
DISCUSSION
There has been interest in resistance mechanisms to new quinolones that show high antibacterial activity against gram-positive and gram-negative bacteria, including nalidixic acid-resistant strains. It has been reported that resistance mechanisms to nalidixic acid in E. coli are alterations in subunits A and B of DNA gyrase and penetration of the drug through the bacterial cell membrane (3, 16, 17, 28) . Several studies of norfloxacin resistance mechanisms have been reported (2, 25, 31) ; however, mechanisms of resistance to new quinolones such as norfloxacin and ciprofloxacin have not been studied in detail until quite recently. Recently, Hooper et al. (15) reported that norfloxacin-resistant mutants obtained by serial passage on an agar plate with an increasing norfloxacin concentration showed alterations in the DNA gyrase A subunit and in the OmpF outer membrane porin protein.
In this study we also demonstrated changes in three distinct loci that resulted in less susceptibility to norfloxacin as a result of an alteration in DNA gyrase or in the outer membrane porin protein. These three types of mutants were less susceptible to norfloxacin and ciprofloxacin than was the parent strain, although these mutants remained susceptible to a concentration of 0.39 ,ug/ml or less. The gyrA (norA) mutant that showed a high level of resistance to nalidixic acid (MIC, 100 pug/ml) remained relatively susceptible to new quinolones. Sato (10, 19, 20) , and the mutants demonstrate increased resistance to antibiotics passing through this porin. We found previously that quinolones penetrated the outer membrane of E. coli K-12 through the OmpF porin (13); those findings were confirmed in this study.
It was known that the structural gene (ompF) and regulatory genes (ompB locus, including ompR and envZ) of the OmpF porin protein were located at 21 and 75 min, respectively, on the E. coli K-12 chromosome (1, 26, 30) . Hooper et al. (15) found that the nfxB norfloxacin-resistant mutation that was associated with additional resistances to tetracycline, chloramphenicol, and cefoxitin and with decreased OmpF porin protein also mapped between 20 and 22 min. In contrast, our norB mutant lacking the OmpF protein mapped at about 34 min. It was reported previously (7) that amplifiable resistance to tetracycline, chloramphenicol, and other unrelated antimicrobial agents, including nalidixic acid, was mediated by the marA (for multiple antibiotic resistance) locus and that this locus mapped at 34 min on the E. coli K-12 chromosome. Expression of phenotypes of marA was temperature sensitive, but a norB mutant could express its phenotypes at 42°C (data not shown). However, the map VOL. 30, 1986 on January 5, 2018 by guest http://aac.asm.org/ Downloaded from position and multiple resistance phenotype of marA are considerably similar to those of norB; therefore, it would be interesting to clarify the correlation between marA and norB genes. This should be tested in further studies. At present the function of this gene (norB) is unclear, but it may regulate OmpF protein production. There is a possibility that norB, like nfxB (15) , is a previously unidentified locus affecting ompF expression.
The norC mutant showed the same susceptibility to hydrophobic quinolones and antibiotics as the lipopolysaccharide-deficient (rfaE) mutant of Salmonella typhimurium (13) .
Furthermore, resistance to phages P1 and T4 and cell surface hydrophobicity changes suggest that the norC mutant may be of the rough (heptose-deficient) type. The norC mutant was also altered in OmpF proteins, as evidenced by the loss of susceptibility to TuIa and analysis of outer membrane proteins by sodium dodecyl sulfate-gel electrophoresis. Defects have been observed in the composition of outer membrane proteins of heptose-deficient mutants of E. coli K-12 (11); therefore, an alteration in the OmpF protein of the norC mutant might be closely correlated with a defect in its lipopolysaccharide core. The norC mutation was located near lac (8 min) on the E. coli chromosome. The acrA and lpcA mutants, showing hypersusceptibility to hydrophobic antibiotics, dyes, and detergents, are located at 11 and 6 min, respectively, on the E. coli chromosome (1, 4) . The phenotype of the acrA mutant closely resembles that of the norC mutant, but the former has normal levels and types of outer membrane proteins (4) . The lpcA (6 min) mutation is likely to be genetically distinct from the norC mutation because a selected lac (8 min) locus coinherits norC with higher frequency than does a selected proA (6 min) locus, and susceptibility of these mutants to T3 and T7 phages is also distinct (11) . But, the results presented in this report, however, do not exclude the possibility that the norC gene is an allele of lpcA or acrA.
We found previously (13) that hydrophobic quinolones such as nalidixic acid might be able to penetrate through the lipid bilayer and that lipopolysaccharide-deficient mutants of S. typhimurium show hypersusceptibility to these compounds. The norC mutant is hypersusceptible to hydrophobic quinolones, suggesting a defect in the outer membrane permeability barrier to these agents or exposure of the hydrophobic region on the outer membrane. The low-level resistance to hydrophilic quinolones such as norfloxacin in KEA16 might be due to a decrease in OmpF porin protein and not to changes in lipopolysaccharide. Results of this study emphasize our previous finding (13) that the outer membrane permeability of new quinolones differs from that of old quinolones such as nalidixic and piromidic acids. This might be one of the reasons for incomplete cross-resistance among quinolones.
Mutations affecting subunit A of DNA gyrase or outer membrane permeability caused an increase in resistance to new quinolones; however, the mutants remained susceptible to clinically achievable levels of these compounds. These results indicate that mutants of E. coli resistant to high levels of new quinolones, unlike to old quinolones, cannot be easily obtained by a single mutation and that multiple mutations might be necessary for high-level resistance to norfloxacin and other new quinolones. Furthermore, the norB and norC mutants lacking OmpF porin show a lower growth rate than the gyrA mutant and the wild-type strain. In particular, norC mutant showed hypersusceptibility to animal serum (data not shown). These results suggest that emergence of norB and norC type mutants is unlikely to occur in vivo.
